\n\t\t\tLet our global subject matter experts broaden your perspective with timely insights and opinions you\n\t\t\tcan’t find anywhere else.\n\t\t
During your trial you will have complete digital access to FT.com with everything in both of our Standard Digital and Premium Digital packages.
Standard Digital includes access to a wealth of global news, analysis and expert opinion. Premium Digital includes access to our premier business column, Lex, as well as 15 curated newsletters covering key business themes with original, in-depth reporting. For a full comparison of Standard and Premium Digital,Change the plan you will roll onto at any time during your trial by visiting the “Settings & Account” section.
You may also opt to downgrade to Standard Digital, a robust journalistic offering that fulfils many user’s needs. Compare Standard and Premium DigitalAny changes made can be done at any time and will become effective at the end of the trial period, allowing you to retain full access for 4 weeks, even if you downgrade or cancel.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Despite abandoning zero-Covid, China’s economic challenges are huge\n\t\t\tLet our global subject matter experts broaden your perspective with timely insights and opinions you\n\t\t\tcan’t find anywhere else.\n\t\t
Read more »
Correlating circulating adipokine levels with COVID-19 severityCorrelating circulating adipokine levels with COVID-19 severity Coronavirus Disease COVID Diagnostic adipokine IntJObesity
Read more »
No benefit of low dose apixaban following acute COVID-19No benefit of low dose apixaban following acute COVID-19 Apixaban Coronavirus Disease COVID medrxivpreprint Cambridge_Uni LivUni imperialcollege unibirmingham EdinburghUni
Read more »
The debilitating effects of long-COVID in the U.S.The debilitating effects of long-COVID in the U.S. Coronavirus Disease COVID19 LongCOVID medrxivpreprint JohnsHopkinsSPH
Read more »
Research reveals that a viral toxin may contribute to the severity of COVID-19Research reveals that a viral toxin may contribute to the severity of COVID-19 Coronavirus Disease COVID Protein SARSCoV2 SpikeProtein Vascular NatureComms
Read more »
More exercise linked to less-severe COVID-19 outcomesKaiser Permanente members who were more physically active prior to being diagnosed with COVID-19 had a lower risk of severe outcomes, according to research published Dec. 15, 2022, in the American Journal of Preventive Medicine.
Read more »